Skip to main content

New story in Health from Time: ‘No One in the World Is Safe Until Everybody’s Safe.’ Why a Globally Accessible Vaccine Is Crucial to Ending the COVID-19 Pandemic



If the COVID-19 pandemic has shown us anything, it’s the interconnected nature of our world. A virus that originated in Wuhan, China, has now spread to virtually every corner of the globe.

The pandemic has exposed how globalization can help a highly contagious virus take root. But there’s another side to the coin. The global community needs to harness that same interconnectedness to emerge from the pandemic stronger than ever, says Ngozi Okonjo-Iweala, board chair for the Global Alliance for Vaccines and Immunization (GAVI).

“No one in the world is safe until everybody’s safe,” Okonjo-Iweala said during a a TIME 100 Talks discussion on finding hope in the midst of the pandemic. “No country is safe until every country is safe,” she says, regardless of their economic standing.

Partnership is something Okonjo-Iweala knows well. GAVI works with the World Health Organization (WHO), UNICEF, the World Bank, the Bill & Melinda Gates Foundation and other partners to increase access to vaccines for children living in underserved nations. Since its formation in 2000, it has helped bring vaccines to more than 760 million children, according to its website.

Okonjo-Iweala, who has previously served as Nigeria’s minister for both finance and foreign affairs, emphasized that a COVID-19 vaccine, when it is ready, must be accessible to people across the world, in countries both rich and poor. Given the scale of that operation—millions of doses of a new vaccine—the pharmaceutical industry will have to think “not about profits to be made, but getting access to all of humanity.”

Part of that effort will also have to focus on reducing fears about vaccination, Okonjo-Iweala acknowledged. Anti-vaccine sentiment was rising worldwide—and threatening public health—even before the COVID-19 pandemic, but fear and uncertainty around the unknown virus is likely to give it new vitriol. To encourage widespread compliance with vaccination, Okonjo-Iweala says health groups should partner with religious, cultural and community leaders, as well as community groups, to get out the message that “when this vaccine is available, no one will allow it to be administered unless they’re sure of the safety and quality.”

Getting large swaths of the world’s population vaccinated is as much an economic concern as a health one, Okonjo-Iweala says, since the economy cannot truly recover while an infectious disease remains a major global concern. For that reason, she adds, countries should not rush to reopen before science says they’re ready.

And when they do, Okonjo-Iweala says they should take the opportunity to rebuild better than before, with an eye toward environmental sustainability, economic equality and global cooperation.

“This is not the last pandemic we’re going to have,” she says. “So we better make the world a better place now. Let’s bring everyone up so we can survive and not perish.”

This article is part of #TIME100Talks: Finding Hope, a special series featuring leaders across different fields sharing their ideas for navigating the pandemic. Want more? Sign up for access to more virtual events, including live conversations with influential newsmakers.

Labels:

Popular posts from this blog

New story in Health from Time: COVID-19 Has Been ‘Apocalyptic’ for Public Transit. Will Congress Offer More Help?

While trying to get to work over the past few months, Brittany Williams, a Seattle home care worker, has often been passed by two or three buses before one stops to let her board. Buses in her area that once carried anywhere from about 50 to 100 passengers have been limited to between 12 and 18 to prevent overcrowding in response to coronavirus, and Williams’ commute, typically a half-hour ride, now takes more than double that time. Other Seattle transit riders have described budgeting as much as an extra hour per trip to account for the reduced capacity, eating into their time at work, school or with family. Even with the ridership limits in place, Williams, 34, doesn’t feel safe on public transit. Some passengers don’t wear face coverings, and bus drivers sometimes ignore capacity limits, she says. On one ride with her seven-year-old son, she decided to get off at a stop far from her home after a driver allowed a crowd of people to board. “It’s very trying. I’ll put...
Read more

New story in Health from Time: A Montana Care Home Refused Free COVID-19 Tests. Now, Nearly Every Resident Has Coronavirus

(BILLINGS, Mont.) — It was meant to be a last line of defense to protect the most vulnerable as the coronavirus spread across the United States : Montana officials offered free testing in May for staff and residents at assisted living and long-term care facilities. But not all of them followed through, according to state data, including a facility in Billings, Montana’s largest city, that cares for people with dementia and other memory problems. The virus has infected almost every resident and killed eight, accounting for almost a quarter of Montana’s 34 confirmed deaths. Thirty-six employees also have tested positive at the facility where 59 people lived before the deaths began. Read more: ‘It’s Getting Worse.’ Nursing Home Workers Confront Risks in Facilities Devastated by Coronavirus While Montana’s rates of confirmed infections and deaths are much lower than other parts of the country, the outbreak at Canyon Creek Memory Care illustrates that even the most simple an...
Read more

New story in Health from Time: An At-Home Coronavirus Test May Be On the Way in the U.S.

As cases of COVID-19 continue to climb in the U.S. , there’s a new urgency to make sure there are as many tests as possible to diagnose people who have symptoms that might indicate an infection. Knowing if people are positive is important for guiding their next steps: self-isolation, avoiding contact with others, and, if their symptoms get worse, seeking medical care. To date, access to tests has been spotty at best across the country, and while more kits are now available than even a week ago , most are gene-based assays that take several days for commercial labs to process and produce results. That may change in about two months if the Food and Drug Administration (FDA) gives Emergency Use Authorization to the first blood-based COVID-19 test in the U.S. Scanwell Health, an at-home test company based in California, licensed the rights to a test developed by Chinese company Innovita, which was used extensively at the height of country’s epidemic earlier this year. “The ...
Read more